In addition, miR-128 enhances dendritic cell-mediated anti-tumor immunity via targeting p38 mitogen activated protein kinase (MAPK) signaling pathway in C57BL/6 mice bearing B16 melanoma [36]. Here, MAPK14 is linked to neoplasm.